Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure.
Ghoneem A, Bhatti AW, Khadke S, Mitchell J, Liu J, Zhang K, Trachtenberg B, Wechalekar A, Cheng RK, Baron SJ, Nohria A, Lenihan D, Ganatra S, Dani SS. Ghoneem A, et al. Among authors: wechalekar a. Curr Probl Cardiol. 2023 Jun;48(6):101667. doi: 10.1016/j.cpcardiol.2023.101667. Epub 2023 Feb 23. Curr Probl Cardiol. 2023. PMID: 36828040 Review.
Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.
Cheng R, Kittleson MM, Wechalekar AD, Alvarez-Cardona J, Mitchell JD, Scarlatelli Macedo AV, Dutra JPP, Campbell CM, Liu JE, Landau HJ, Davis MK, Morrissey S, Casselli S, Lousada I, Seabra-Garcez JD, Szor RS, Ganatra S, Trachtenberg B, Maurer MS, Stockerl-Goldstein K, Lenihan D. Cheng R, et al. Among authors: wechalekar ad. Heart. 2024 May 23;110(12):823-830. doi: 10.1136/heartjnl-2023-323502. Heart. 2024. PMID: 38267197 Review.
Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis.
Patel RK, Bandera F, Venneri L, Porcari A, Razvi Y, Ioannou A, Chacko L, Martinez-Naharro A, Rauf MU, Knight D, Brown J, Petrie A, Wechalekar A, Whelan C, Lachmann H, Muthurangu V, Guazzi M, Hawkins PN, Gillmore JD, Fontana M. Patel RK, et al. Among authors: wechalekar a. JAMA Cardiol. 2024 Apr 1;9(4):367-376. doi: 10.1001/jamacardio.2024.0022. JAMA Cardiol. 2024. PMID: 38446436
Stratifying Disease Progression in Patients With Cardiac ATTR Amyloidosis.
Ioannou A, Cappelli F, Emdin M, Nitsche C, Longhi S, Masri A, Cipriani A, Zampieri M, Colio F, Poledniczek M, Porcari A, Razvi Y, Aimo A, Vergaro G, De Michieli L, Rauf MU, Patel RK, Villanueva E, Lustig Y, Venneri L, Martinez-Naharro A, Lachmann H, Wechalekar A, Whelan C, Petrie A, Hawkins PN, Solomon S, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: wechalekar a. J Am Coll Cardiol. 2024 Mar 1;83(14):1276-91. doi: 10.1016/j.jacc.2023.12.036. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38530684 Free PMC article.
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis.
Ioannou A, Fumagalli C, Razvi Y, Porcari A, Rauf MU, Martinez-Naharro A, Venneri L, Moody W, Steeds RP, Petrie A, Whelan C, Wechalekar A, Lachmann H, Hawkins PN, Solomon SD, Gillmore JD, Fontana M. Ioannou A, et al. Among authors: wechalekar a. J Am Coll Cardiol. 2024 May 7:S0735-1097(24)06893-1. doi: 10.1016/j.jacc.2024.04.011. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38739065 Free article.
Native T1 mapping in transthyretin amyloidosis.
Fontana M, Banypersad SM, Treibel TA, Maestrini V, Sado DM, White SK, Pica S, Castelletti S, Piechnik SK, Robson MD, Gilbertson JA, Rowczenio D, Hutt DF, Lachmann HJ, Wechalekar AD, Whelan CJ, Gillmore JD, Hawkins PN, Moon JC. Fontana M, et al. Among authors: wechalekar ad. JACC Cardiovasc Imaging. 2014 Feb;7(2):157-65. doi: 10.1016/j.jcmg.2013.10.008. Epub 2014 Jan 8. JACC Cardiovasc Imaging. 2014. PMID: 24412190 Free article.
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Gillmore JD, et al. Among authors: wechalekar ad. Circulation. 2016 Jun 14;133(24):2404-12. doi: 10.1161/CIRCULATIONAHA.116.021612. Epub 2016 Apr 22. Circulation. 2016. PMID: 27143678
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, Rowczenio DM, Gilbertson JA, Hutt DF, Rezk T, Strehina SG, Caringal-Galima J, Manwani R, Sharpley FA, Wechalekar AD, Lachmann HJ, Mahmood S, Sachchithanantham S, Drage EPS, Jenner HD, McDonald R, Bertolli O, Calleja A, Hawkins PN, Gillmore JD. Lane T, et al. Among authors: wechalekar ad. Circulation. 2019 Jul 2;140(1):16-26. doi: 10.1161/CIRCULATIONAHA.118.038169. Epub 2019 May 21. Circulation. 2019. PMID: 31109193
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Ravichandran S, Cohen OC, Law S, Sachchithanantham S, Mahmood S, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD. Ravichandran S, et al. Among authors: wechalekar ad. Br J Haematol. 2021 Aug;194(3):587-597. doi: 10.1111/bjh.17636. Epub 2021 Jun 29. Br J Haematol. 2021. PMID: 34189728
259 results